Accessible online at: www.karger.com/dsu Dear Editor With interest we read the article by Abir et al. [1] entitled ‘Surgical treatment of achalasia: Current status and controversies’ including a brilliant overview on pharmacologic, interventional and surgical treatment modalities. However, we would like to point out the following considerations on the topic: (1) In our institution we use the ‘Starck dilator’, a mechanical device with four expandable metal branches allowing a maximal diameter of up to 4 cm. Using the Starck dilator we obtain similar success rates without perforation [2], when compared to up to 15% as reported for pneumatic dilatation [1]. This may at least in part be due to a more uniformed application of mechanical force directed towards the circumference of the esophagogastric junction via the four expandable metal branches of this mechanical dilator [3]. In addition, the Starck dilator is considered to allow direct transmission of tissue resistance to the handset via the metal branches when compared to an air-filled balloon used during pneumatic dilatation, thus indicating successful dilatation of the lower esophageal sphincter. (2) Concerning the surgical treatment of achalasia, we would like to bring to your attention a novel concept including transgastric stapled esophagofundostomy (TSE) and partial fundoplication [4]. In contrast to myotomy [1], TSE results in complete dissection of the left lateral wall of the distal esophagus and the esophagogastric junction, thus suggested to disenable closure of the myotomy. Although still at an experimental level, TSE is suggested to evolve suitable for individuals with end-stage achalasia with or without unsuccessful prior dilatation(s) [5]. The transgastric approach is considered to be advantageous in patients following failed myotomy, where ab externis identification of the musculature covering the esophagogastric junction may be difficult or impossible [6]. (3) In results of the abstract, the authors include balloon dilatation into medical therapy. To our understanding, the term interventional therapy would seem more suitable for dilatation. References
[1]
I. Modlin,et al.
Surgical Treatment of Achalasia: Current Status and Controversies
,
2004,
Digestive Surgery.
[2]
T. Junginger,et al.
Transgastric stapled esophagofundostomy (TSE) and partial fundoplicatio – a technical illustration of a new concept for surgical treatment of achalasia
,
2004,
European Surgery.
[3]
T. Fujihara,et al.
Diquafosol Elicits Increases in Net Cl– Transport through P2Y2 Receptor Stimulation in Rabbit Conjunctiva
,
2004,
Ophthalmic Research.
[4]
M. Nagaya,et al.
Evaluation of Thermoreversible Gelation Polymer for Regeneration of Focal Liver Injury
,
2004,
European Surgical Research.
[5]
M. Schemper,et al.
[Dilatation treatment of achalasia as initial therapy. Results of a prospective study].
,
1996,
Wiener klinische Wochenschrift.
[6]
G. SERRANO REBEIL,et al.
[Treatment of achalasia].
,
1959,
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.